Page last updated: 2024-10-22

amitriptyline and Cancer of Colon

amitriptyline has been researched along with Cancer of Colon in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Preclinical studies have suggested that the long-term use of antidepressants may result in the initiation and/or promotion of tumor in the gastrointestinal tract."1.33Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. ( Arimochi, H; Morita, K, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arimochi, H1
Morita, K1
Adams, S1

Other Studies

2 other studies available for amitriptyline and Cancer of Colon

ArticleYear
Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells.
    European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Apoptosis; Cell Cycle; Cell Proliferation; Cell Sur

2006
Amitriptyline suppositories.
    The New England journal of medicine, 1982, Apr-22, Volume: 306, Issue:16

    Topics: Amitriptyline; Colonic Neoplasms; Depression; Female; Humans; Middle Aged; Suppositories; Terminal C

1982